GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder

Journal of Affective Disorders

Volumn 142, Issue 1-3, 2012, Pages 315-322

  Kishi, Taro ^a,b   Ichinose, Hiroshi ^c   Yoshimura, Reiji ^d   Fukuo, Yasuhisa ^b   Kitajima, Tsuyoshi ^b   Inada, Toshiya ^e   Kunugi, Hiroshi ^f   Kato, Tadafumi ^g   Yoshikawa, Takeo ^g   Ujike, Hiroshi ^h   Musso, Giovanna M ^a   Umene Nakano, Wakako ^d   Nakamura, Jun ^d   Ozaki, Norio ⁱ   Iwata, Nakao ^b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^e SEIWA HOSPITAL   (Japan)

^f NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^g RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^h OKAYAMA UNIVERSITY   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bipolar disorder; Case control study; GTP cyclohydrolase gene (GCH1); Major depressive disorder; Pharmacogenetic study; Tetrahydrobiopterin (BH4)

Indexed keywords

FLUVOXAMINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; HAMILTON SCALE; HAPLOTYPE; HUMAN; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUVOXAMINE; GENE FREQUENCY; GENOTYPE; GTP CYCLOHYDROLASE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN UPTAKE INHIBITORS;

EID: 84868118364     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.05.004     Document Type: Article

References (28)

1. M.T. Abou-Saleh, D.N. Anderson, J. Collins, K. Hughes, R.J. Cattell, C.G. Hamon, and J.A. Blair The role of pterins in depression and the effects of antidepressive therapy Biological Psychiatry 38 1995 458 463
2. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265
3. J.A. Blair, P.A. Barford, C. Morar, A.E. Pheasant, C.G. Hamon, S.B. Whitburn, R.J. Leeming, G.P. Reynolds, and A. Coppen Tetrahydrobiopterin metabolism in depression Lancet 2 1984 163
4. T. Bottiglieri, K. Hyland, M. Laundy, P. Godfrey, M.W. Carney, B.K. Toone, and E.H. Reynolds Folate deficiency, biopterin and monoamine metabolism in depression Psychological Medicine 22 1992 871 876
5. C.L. Bowden Strategies to reduce misdiagnosis of bipolar depression Psychiatry Services 52 2001 51 55
6. P.G.C.S Committee A framework for interpreting genome-wide association studies of psychiatric disorders Molecular Psychiatry 14 10-17 2009
7. A. Coppen, C. Swade, S.A. Jones, R.A. Armstrong, J.A. Blair, and R.J. Leeming Depression and tetrahydrobiopterin: the folate connection Journal Affective Disorder 16 1989 103 107
8. A. Dhir, and S.K. Kulkarni Nitric oxide and major depression Nitric Oxide 24 2011 125 131
9. F. Dudbridge Pedigree disequilibrium tests for multilocus haplotypes Genetic Epidemiology 25 2003 115 121
10. B.W. Dunlop, and C.B. Nemeroff The role of dopamine in the pathophysiology of depression Archives of General Psychiatry 64 2007 327 337
11. R. Hashimoto, N. Ozaki, T. Ohta, Y. Kasahara, N. Kaneda, and T. Nagatsu The plasma tetrahydrobiopterin levels in patients with affective disorders Biological Psychiatry 28 1990 526 528
12. H. Ichinose, T. Ohye, E. Takahashi, N. Seki, T. Hori, M. Segawa, Y. Nomura, K. Endo, H. Tanaka, and S. Tsuji Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene Nature Genetics 8 1994 236 242
13. S. Kasper, M. Dotsch, H. Kick, A. Vieira, and H.J. Moller Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects European Neuropsychopharmacology 3 1993 13 21
14. C. Kealey, S. Roche, E. Claffey, and P. McKeon Linkage and candidate gene analysis of 14q22-24 in bipolar disorder: support for GCHI as a novel susceptibility gene America Journal of Medical Genomics B Neuropsychiatry Genetics 136B 2005 75 80
15. T. Kishi, R. Yoshimura, T. Kitajima, T. Okochi, T. Okumura, T. Tsunoka, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, Y. Fukuo, H. Naitoh, W. Umene-Nakano, T. Inada, J. Nakamura, N. Ozaki, and N. Iwata SIRT1 gene is associated with major depressive disorder in the Japanese population Journal Affective Disorder 126 2010 167 173
16. P.C. McHugh, P.R. Joyce, X. Deng, and M.A. Kennedy A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants Pharmacogenomics Journal 11 2011 207 213
17. P.C. McHugh, P.R. Joyce, and M.R. Kennedy Polymorphisms of sepiapterin reductase gene alter promoter activity and may influence risk of bipolar disorder Pharmacogenetics Genomics 19 2009 330 337
18. T.M. McLeod, A.L. Lopez-Figueroa, and M.O. Lopez-Figueroa Nitric oxide, stress, and depression Psychopharmacology Bulletin 35 2001 24 41
19. H. Miura, H. Qiao, T. Kitagami, and T. Ohta Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin in the mouse hippocampus Neuropharmacology 46 2004 340 348
20. H. Miura, H. Qiao, T. Kitagami, T. Ohta, and N. Ozaki Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice Psychopharmacology (Berlin) 177 2005 307 314
21. R. Peveler, and T. Kendrick Selective serotonin reuptake inhibitors: THREAD trial may show way forward British Medical Journal 330 2005 420 421
22. S. Russo, I.P. Kema, F. Bosker, J. Haavik, and J. Korf Tryptophan as an evolutionarily conserved signal to brain serotonin: molecular evidence and psychiatric implications World Journal of Biological Psychiatry 10 2009 258 268
23. G. Salvadore, J.A. Quiroz, R. Machado-Vieira, I.D. Henter, H.K. Manji, and C.A. Zarate Jr. The neurobiology of the switch process in bipolar disorder: a review Journal of Clinical Psychiatry 71 2010 1488 1501
24. A.D. Skol, L.J. Scott, G.R. Abecasis, and M. Boehnke Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies Nature Genetics 38 2006 209 213
25. C. Sumi-Ichinose, F. Urano, R. Kuroda, T. Ohye, M. Kojima, M. Tazawa, H. Shiraishi, Y. Hagino, T. Nagatsu, T. Nomura, and H. Ichinose Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice Journal of Biological Chemistry 276 2001 41150 41160
26. I. Tegeder, M. Costigan, R.S. Griffin, A. Abele, I. Belfer, H. Schmidt, C. Ehnert, J. Nejim, C. Marian, J. Scholz, T. Wu, A. Allchorne, L. Diatchenko, A.M. Binshtok, D. Goldman, J. Adolph, S. Sama, S.J. Atlas, W.A. Carlezon, A. Parsegian, J. Lotsch, R.B. Fillingim, W. Maixner, G. Geisslinger, M.B. Max, and C.J. Woolf GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence Nature Medicine 12 2006 1269 1277
27. B. Thony, G. Auerbach, and N. Blau Tetrahydrobiopterin biosynthesis, regeneration and functions Biochemical Journal 347 Pt 1 2000 1 16
28. L. Zhang, F. Rao, K. Zhang, S. Khandrika, M. Das, S.M. Vaingankar, X. Bao, B.K. Rana, D.W. Smith, J. Wessel, R.M. Salem, J.L. Rodriguez-Flores, S.K. Mahata, N.J. Schork, M.G. Ziegler, and D.T. OConnor Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk Journal of Clinical Investigations 117 2007 2658 2671